Centrale D'approvisionnement En Medicaments Essentiels De Kolwezi

Centrale D'approvisionnement En Medicaments Essentiels De Kolwezi, doing business as Camekol, is a non-profit organization operating as a subcontractor delivering last-mile pharmaceutical distribution and warehousing services to US Agency for International Development (USAID) global health programs. Camekol does not hold prime federal contracts; all three recent awards are sub-awards under Chemonics International, Inc. on USAID's Global Health Supply Chain IDIQ (AIDOAAI1500004).

Camekol's federal footprint is nascent and concentrated in HIV/AIDS and malaria commodity distribution. The vendor has received two sub-awards in 2026 for last-mile distribution under the Global Health Supply Chain IDIQ — one for HIV/AIDS and one for malaria — and a single 2025 sub-award for warehousing support on an HIV/AIDS task order, all flowing from Chemonics as prime contractor. Combined obligated dollars across the three awards total $1.5 million. USAID's Bureau for Global Health is the sole customer agency across all awards; 100% of awards flow through the parent GHSC IDIQ vehicle.

Activity emerged in mid-2025 with one award and accelerated to two awards in 2026, suggesting early-stage growth. The vendor characterizes as Administrative Management and General Management Consulting Services under NAICS classification, though the concrete work scope centers on pharmaceutical supply-chain execution — warehousing, inventory management, and distribution logistics for antimalarial and antiretroviral commodities in the Kolwezi region. Camekol's headquarters location and operational geography are Democratic Republic of Congo–based; the vendor's name and business structure signal a Congolese non-profit entity. No recompete risk or additional prime vehicles appear in the source data.